EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives

Chinyere Aloke, Nwogo Ajuka Obasi iD, Patrick Maduabuchi Aja iD, Chinedum Uche Emelike iD, Chinedu Ogbonnia Egwu iD, Olamide Jeje, Chuks Oswald Edeogu, Olalekan Olugbenga Onisuru iD, Obasi Uche Orji, Ikechukwu Achilonu

Viruses · 03.01.2023 · 15 (1) · 146

DOI: 10.3390/v15010146 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 03.01.2023. Verfasst von Chinyere Aloke und 9 weiteren Autor:innen. Beteiligte Einrichtung: Protein Structure-Function and Research Unit, School of Molecular and Cell Biology, Faculty of Science, University of the Witwatersrand, Braamfontein…. Hauptthemen laut MEDLINE: Lassa Fever, Viral Vaccines. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lassa fever (LF) is a rodent-borne disease that threatens human health in the sub-region of West Africa where the zoonotic host of Lassa virus (LASV) is predominant. Currently, treatment options for LF are limited and since no preventive vaccine is approved for its infectivity, there is a high mortality rate in endemic areas. This narrative review explores the transmission, pathogenicity of LASV, advances, and challenges of different treatment options. Our findings indicate that genetic diversity among the different strains of LASV and their ability to circumvent the immune system poses a critical challenge to the development of LASV vaccines/therapeutics. Thus, understanding the biochemistry, physiology and genetic polymorphism of LASV, mechanism of evading host immunity are essential for development of effective LASV vaccines/therapeutics to combat this lethal viral disease. The LASV nucleoprotein (NP) is a novel target for therapeutics as it functions significantly in several aspects of the viral life cycle. Consequently, LASV NP inhibitors could be employed as effective therapeutics as they will potentially inhibit LASV replication. Effective preventive control measures, vaccine development, target validation, and repurposing of existing drugs, such as ribavirin, using activity or in silico-based and computational bioinformatics, would aid in the development of novel drugs for LF management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa FeverViral VaccinesHumansLassa virusAfrica, WesternVirus Replication

Stichwörter der Autor:innen

Lassa feverLassa virusnucleoproteinribavirintarget validation

Substanzen

Viral Vaccines

Autor:innen und Institutionen

  • Protein Structure-Function and Research Unit, School of Molecular and Cell Biology, Faculty of Science, University of the Witwatersrand, Braamfontein, Johannesburg 2050, South Africa.
  • Department of Medical Biochemistry, Alex Ekwueme Federal University Ndufu-Alike, Abakaliki PMB 1010, Ebonyi State, Nigeria.
  • Department of Biochemistry, Faculty of Biological Sciences, Ebonyi State University, Abakaliki PMB 053, Ebonyi State, Nigeria.
  • Department of Biochemistry, Faculty of Medicine, Mbarara University of Science and Technology (MUST), Mbarara P.O. Box 1410, Uganda.
  • Department of Medical Biochemistry, Kampala International University, Bushenyi, Ishaka P.O. Box 71, Uganda.
  • Department of Physiology, Alex Ekwueme Federal University Ndufu-Alike, Abakaliki PMB 1010, Ebonyi State, Nigeria.

ORCID-Profile: Nwogo Ajuka Obasi, Patrick Maduabuchi Aja, Chinedum Uche Emelike, Chinedu Ogbonnia Egwu, Olalekan Olugbenga Onisuru

Zitieren

APA

Aloke, C., Obasi, N. A., Aja, P. M., Emelike, C. U., Egwu, C. O., Jeje, O., Edeogu, C. O., Onisuru, O. O., Orji, O. U., & Achilonu, I. (2023). Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives. Viruses, 15(1), 146. https://doi.org/10.3390/v15010146

Vancouver

Aloke C, Obasi NA, Aja PM, Emelike CU, Egwu CO, Jeje O, et al. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives. Viruses. 2023;15(1):146. doi:10.3390/v15010146

BibTeX
@article{Aloke2023,
  author = {Aloke, Chinyere and Obasi, Nwogo Ajuka and Aja, Patrick Maduabuchi and Emelike, Chinedum Uche and Egwu, Chinedu Ogbonnia and Jeje, Olamide and Edeogu, Chuks Oswald and Onisuru, Olalekan Olugbenga and Orji, Obasi Uche and Achilonu, Ikechukwu},
  title = {Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {146},
  doi = {10.3390/v15010146}
}
Kostenlos starten →